Mochi Health cuts compounded semaglutide price to $60 a month
The telehealth platform tied pricing to dose level and added an in-platform bloodwork service, Mochi Labs, in most states.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 29 07:32 ETSource: usatoday.com
The wire
- 01Mochi Health moved to dose-based pricing, with compounded semaglutide starting at $60 per month and compounded tirzepatide at $90, plus memberships from $39 for the first month.
- 02Dose-tiered pricing undercuts entry costs for new patients and signals continued price competition among telehealth sellers of compounded incretins.
- 03Compounded semaglutide and tirzepatide are not FDA-approved; Mochi Labs is unavailable in New York, New Jersey, Rhode Island and Hawaii, and the pricing claims are the company's own.
From the source
Read at usatoday.comA popular GLP-1 provider just made its weight loss medications cheaper
Mochi Health just lowered the cost of its compounded GLP-1 medications while adding a new lab-testing service designed to help patients track key health markers during treatment.
